General Information of the Compound
Compound ID |
CP0848620
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(E)-5-((7-bromo-1H-indol-3-yl)methylene)-2-iminoimidazolidin-4-one
Show/Hide
|
||||||||||||||||||
Formula |
C12H9BrN4O
|
||||||||||||||||||
Molecular Weight |
305.135
|
||||||||||||||||||
Canonical SMILES |
N=C1NC(=O)/C(=C\c2c[nH]c3c(Br)cccc23)N1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C12H9BrN4O/c13-8-3-1-2-7-6(5-15-10(7)8)4-9-11(18)17-12(14)16-9/h1-5,15H,(H3,14,16,17,18)/b9-4+
Show/Hide
|
||||||||||||||||||
InChIKey |
LWVFMDTWYOYNOZ-RUDMXATFSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02507, 5-hydroxytryptamine receptor 1E
Protein ID: PT01492, 5-hydroxytryptamine receptor 2A
Protein ID: PT01019, 5-hydroxytryptamine receptor 2B
Protein ID: PT00939, 5-hydroxytryptamine receptor 2C
Protein ID: PT01513, 5-hydroxytryptamine receptor 5A
Protein ID: PT01354, 5-hydroxytryptamine receptor 6